Synthesis of [C-11]uric acid, using [C-11]phosgene, as a possible biomarker in PET imaging for diagnosis of gout

[摘要]：The synthesis and in vivo evaluation of C-11 -labeled uric acid ([C-11]1), a potential imaging agent for the diagnosis of urate-related life-style diseases, was performed using positron emission tomography (PET) image analysis. First, the synthesis of [C-11]1 was achieved by reacting 5,6-diaminouracil (2) with C-11-labeled phosgene ([C-11]COCl2). The radiochemical yield of [C-11]1 was 37 +/- 7% (decay-corrected based on [C-11]COCl2) with specific radioactivities of 96-152 GBq/mu mol at the end of synthesis (n = 6). The average time of radiosynthesis from the end of bombardment, including formulation, was about 30 min with >98% radiochemical purity. Second, the synthetic approach to [C-11]1 was optimized using 5,6-diaminouracil sulfate (3) with [C-11]COCl2 in the presence of 1,8-bis(dimethylamino) naphthalene. [C-11]1 was synthesized in 36 +/- 6% radiochemical yield, 89-142 GBq/mu mol of specific radioactivities, and 98% radiochemical purity by this method (n = 5). This allowed the synthesis of [C-11]1 to be carried out repeatedly and the radiochemical yield, specific radioactivities, average time of synthesis, and radiochemical purity of [C-11]1 were similar to those obtained using 2. PET studies in rats showed large differences in the accumulation of radioligand in the limbs under normal and hyperuricemic conditions. Thus, an efficient and convenient automated synthesis of [C-11]1 has been developed, and preliminary PET evaluation of [C-11]1 confirmed the increased accumulation of radioactivity in the limbs of a rat model of hyperuricemia. (C) 2011 Elsevier Ltd. All rights reserved.

[全文传递流程]：

一般上传文献全文的时限在1个工作日内